Application Lycojaponicumin C in the manufacture of a medicament for the treatment of gastric

The present invention discloses Lycojaponicumin? Application of C in the manufacture of a medicament treatment of gastric cancer, which belongs to the field of pharmaceutical technology. Evaluation of anti-tumor activity of the present invention is found by in vitro MTT, Lycojaponicumin? Human gastric cancer cell line C HGC-27, growth of MGC-803, BGC-823 and SGC-7901 also significantly inhibited. Therefore, Lycojaponicumin? C can be used for making an anti-gastric cancer drugs, it has a good development and application prospect. For Lycojaponicumin present invention? C in the manufacture of a medicament for the treatment of gastric cancer belongs to the first public, since the framework type belonging to a new framework type, and which have unexpectedly strong activity for inhibiting gastric cancer cells.